S&P 500   2,995.68 (+1.00%)
DOW   27,024.80 (+0.89%)
QQQ   193.52 (+1.27%)
AAPL   235.32 (-0.23%)
FB   188.89 (+3.06%)
MSFT   141.58 (+1.45%)
GOOGL   1,242.24 (+2.01%)
AMZN   1,767.38 (+1.78%)
CGC   20.10 (+6.57%)
NVDA   196.37 (+5.28%)
MU   46.46 (+3.54%)
BABA   175.29 (+2.41%)
GE   8.89 (+1.95%)
TSLA   257.89 (+0.36%)
AMD   30.72 (+0.62%)
T   37.90 (+1.15%)
F   9.07 (+2.83%)
ACB   3.76 (+7.12%)
PRI   123.67 (+1.81%)
NFLX   284.25 (-0.45%)
BAC   29.73 (+2.02%)
GILD   65.30 (+1.22%)
DIS   129.76 (+0.05%)
S&P 500   2,995.68 (+1.00%)
DOW   27,024.80 (+0.89%)
QQQ   193.52 (+1.27%)
AAPL   235.32 (-0.23%)
FB   188.89 (+3.06%)
MSFT   141.58 (+1.45%)
GOOGL   1,242.24 (+2.01%)
AMZN   1,767.38 (+1.78%)
CGC   20.10 (+6.57%)
NVDA   196.37 (+5.28%)
MU   46.46 (+3.54%)
BABA   175.29 (+2.41%)
GE   8.89 (+1.95%)
TSLA   257.89 (+0.36%)
AMD   30.72 (+0.62%)
T   37.90 (+1.15%)
F   9.07 (+2.83%)
ACB   3.76 (+7.12%)
PRI   123.67 (+1.81%)
NFLX   284.25 (-0.45%)
BAC   29.73 (+2.02%)
GILD   65.30 (+1.22%)
DIS   129.76 (+0.05%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Denali TherapeuticsAcceleron PharmaRegenxbioAudentes TherapeuticsCoherus Biosciences
SymbolNASDAQ:DNLINASDAQ:XLRNNASDAQ:RGNXNASDAQ:BOLDNASDAQ:CHRS
Price Information
Current Price$15.05$41.92$37.70$28.16$18.89
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$27.86$58.91$79.13$39.99$32.57
% Upside from Price Target85.10% upside40.53% upside109.88% upside42.02% upside72.43% upside
Trade Information
Market Cap$1.47 billion$2.21 billion$1.45 billion$1.31 billion$1.32 billion
Beta2.151.250.821.792.94
Average Volume349,983360,695564,671503,830969,707
Sales & Book Value
Annual Revenue$129.16 million$13.99 million$218.51 millionN/A$1.56 million
Price / Sales11.17157.876.35N/A844.77
CashflowN/AN/A$2.45 per shareN/AN/A
Price / CashN/AN/A15.38N/AN/A
Book Value$5.76 per share$6.32 per share$14.20 per share($7.48) per share($0.57) per share
Price / Book2.616.632.65N/A-33.14
Profitability
Net Income$-36,240,000.00$-118,870,000.00$99.94 million$-128,820,000.00$-209,340,000.00
EPS($0.39)($2.59)$2.38($3.40)($3.22)
Trailing P/E RatioN/AN/A15.84N/AN/A
Forward P/E RatioN/AN/AN/AN/A15.11
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-40.78%-318.84%-88.57%N/AN/A
Return on Equity (ROE)-11.03%-29.51%-15.39%N/AN/A
Return on Assets (ROA)-8.75%-27.13%-14.50%-38.09%-70.62%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.15%0.05%0.01%N/AN/A
Current Ratio10.65%17.11%14.58%14.38%3.36%
Quick Ratio10.66%17.11%14.58%14.38%3.29%
Ownership Information
Institutional Ownership Percentage73.91%90.10%79.48%98.26%95.46%
Insider Ownership Percentage21.20%2.50%13.80%5.30%18.20%
Miscellaneous
Employees179173192207232
Shares Outstanding95.84 million52.69 million36.81 million45.44 million69.76 million
Next Earnings Date11/14/2019 (Estimated)10/29/2019 (Estimated)11/6/2019 (Estimated)11/5/2019 (Estimated)11/14/2019 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
 Denali TherapeuticsAcceleron PharmaRegenxbioAudentes TherapeuticsCoherus Biosciences

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel